EQL Pharma AB (publ)

OM:EQL 株式レポート

時価総額：SEK 1.7b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

EQL Pharma マネジメント

マネジメント 基準チェック /14

EQL Pharma'sの CEO はAxel Schorlingで、 Aug2022年に任命され、 の在任期間は 1.83年です。 は、会社の株式の1.07%を直接所有しており、その価値はSEK 15.55M 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と5.1年です。

主要情報

Axel Schorling

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間1.9yrs
CEOの所有権1.1%
経営陣の平均在職期間1.9yrs
取締役会の平均在任期間5.2yrs

経営陣の近況

We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair

Aug 10
We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair

How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?

Mar 11
How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?

Recent updates

EQL Pharma AB (publ)'s (NGM:EQL) P/E Is Still On The Mark Following 30% Share Price Bounce

Jun 13
EQL Pharma AB (publ)'s (NGM:EQL) P/E Is Still On The Mark Following 30% Share Price Bounce

EQL Pharma (NGM:EQL) Is Doing The Right Things To Multiply Its Share Price

May 14
EQL Pharma (NGM:EQL) Is Doing The Right Things To Multiply Its Share Price

EQL Pharma's (NGM:EQL) Weak Earnings May Only Reveal A Part Of The Whole Picture

Feb 21
EQL Pharma's (NGM:EQL) Weak Earnings May Only Reveal A Part Of The Whole Picture

The Trend Of High Returns At EQL Pharma (NGM:EQL) Has Us Very Interested

Jun 28
The Trend Of High Returns At EQL Pharma (NGM:EQL) Has Us Very Interested

With EPS Growth And More, EQL Pharma (NGM:EQL) Makes An Interesting Case

Apr 28
With EPS Growth And More, EQL Pharma (NGM:EQL) Makes An Interesting Case

EQL Pharma AB (publ)'s (NGM:EQL) 26% Jump Shows Its Popularity With Investors

Feb 24
EQL Pharma AB (publ)'s (NGM:EQL) 26% Jump Shows Its Popularity With Investors

EQL Pharma (NGM:EQL) Is Achieving High Returns On Its Capital

Dec 19
EQL Pharma (NGM:EQL) Is Achieving High Returns On Its Capital

Does EQL Pharma (NGM:EQL) Deserve A Spot On Your Watchlist?

Jun 29
Does EQL Pharma (NGM:EQL) Deserve A Spot On Your Watchlist?

Is EQL Pharma (NGM:EQL) Using Too Much Debt?

Apr 29
Is EQL Pharma (NGM:EQL) Using Too Much Debt?

We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair

Aug 10
We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair

EQL Pharma (NGM:EQL) Hasn't Managed To Accelerate Its Returns

Jun 07
EQL Pharma (NGM:EQL) Hasn't Managed To Accelerate Its Returns

If You Like EPS Growth Then Check Out EQL Pharma (NGM:EQL) Before It's Too Late

Apr 16
If You Like EPS Growth Then Check Out EQL Pharma (NGM:EQL) Before It's Too Late

How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?

Mar 11
How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?

Are EQL Pharma's (NGM:EQL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 21
Are EQL Pharma's (NGM:EQL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Is EQL Pharma AB (publ)'s (NGM:EQL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 03
Is EQL Pharma AB (publ)'s (NGM:EQL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

What We Learned About EQL Pharma's (NGM:EQL) CEO Compensation

Jan 16
What We Learned About EQL Pharma's (NGM:EQL) CEO Compensation

Will the Promising Trends At EQL Pharma (NGM:EQL) Continue?

Dec 28
Will the Promising Trends At EQL Pharma (NGM:EQL) Continue?

What Type Of Shareholders Make Up EQL Pharma AB (publ)'s (NGM:EQL) Share Registry?

Dec 11
What Type Of Shareholders Make Up EQL Pharma AB (publ)'s (NGM:EQL) Share Registry?

EQL Pharma (NGM:EQL) Has Rewarded Shareholders With An Exceptional 436% Total Return On Their Investment

Nov 22
EQL Pharma (NGM:EQL) Has Rewarded Shareholders With An Exceptional 436% Total Return On Their Investment

CEO（最高経営責任者

Axel Schorling (38 yo)

1.9yrs

在職期間

Mr. Axel Schorling has been Independent Director at Gasporox AB (publ) since 2023. Mr. Schörling is President of EQL Pharma AB (publ) from August 15, 2022. He had been the Chief Operating Officer of EQL Ph...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Christer Fahraeus
Founder & Chairman18.5yrsSEK 1.50mデータなし
Axel Schorling
President & CEO1.9yrsデータなし1.07%
SEK 18.5m
Anna Jonsson
Chief Financial Officer2.6yrsデータなし0.047%
SEK 815.5k
Martin Kristofferson
Chief Operating Officer1.9yrsデータなし0.052%
SEK 902.9k
Alexander Brising
Chief Commercial Officerno dataデータなし0.88%
SEK 15.2m
Carl Lindgren
Chief Business Development Officer1.3yrsデータなしデータなし

1.9yrs

平均在職期間

50yo

平均年齢

経験豊富な経営陣: EQLの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称ポジション在職期間報酬所有権
Christer Fahraeus
Founder & Chairman18.5yrsSEK 1.50mデータなし
Rajiv Modi
Non Independent Director9.5yrsデータなしデータなし
Linda Neckmar
Independent Director4.5yrsデータなし0.0086%
SEK 148.5k
Anders Mansson
Independent Director5.9yrsデータなし0.034%
SEK 594.0k
Per Svangren
Independent Director3.5yrsデータなし0.034%
SEK 594.0k
Per Ollermark
Independent Director3.5yrsデータなしデータなし

5.2yrs

平均在職期間

58yo

平均年齢

経験豊富なボード: EQLの 取締役会 は 経験豊富 であると考えられます ( 5.1年の平均在任期間)。